Appethyl® as part of a meal prolongs satiety/reduces cravings after that meal: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Year: 2026
Type: article
Abstract: Following an application from Lars Jansson, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Sweden, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to ‘Appethyl® as part of a meal prolongs satiety/reduces cravings after that meal’. Appethyl® is an aqueous extract from spinach leaves standardised by the manufacturing process and its lipase/colipase inhibition capacity in vitro. The Panel had evaluated the characterisation of Appethyl® in a previous opinion and as there were no changes made to the characterisation of Appethyl® in the current application, the Panel considers the food/constituent sufficiently characterised. The Panel notes that the claimed effect refers to changes in appetite ratings, which are not considered a beneficial physiological effect per se, and that no beneficial physiological effect resulting from changes in appetite ratings has been identified by the applicant. The Panel concludes that a cause‐and‐effect relationship between the consumption of Appethyl® and a beneficial physiological effect cannot be established in the context of this application.
Source: EFSA Journal
Authors: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Montaña Cámara, Jacqueline Castenmiller, Stefaan de Henauw, Karen‐Ildico Hirsch‐Ernst, Angeles Jos, Alexandre Maciuk, Inge Mangelsdorf, Breige McNulty, Androniki Naska, Kristina Pentieva, Frank Thies, Ines Drenjančević, Thibault Fiolet, Alfonso Siani
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,400
OpenAlex ID: W7223020625